KAITLYN FLYNN: Open Payments
NPI 1497206957 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 12 payments from 6 companies in 2025. Trend: 2023 $644 · 2024 $775 · 2025 $429
Food & beverage: $429
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $122 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $121 |
| Abbott Laboratories | 3 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $59 |
| AstraZeneca Pharmaceuticals LP | 1 | $31 |
| AtriCure, Inc. | 1 | $22 |
Products named: LEQVIO, LifeVest, AVEIR, JARDIANCE, WAINUA, SYNERGY ABLATION SYSTEM.
Industry payments across CT — which companies pay providers there.
